, Tracking Stock Market Picks
Enter Symbol:
Hologic, Inc. (HOLX) [hlAlert]

up 128.34 %

Hologic, Inc. (HOLX) rated Overweight with price target $37.50 by Lehman Brothers

Posted on: Tuesday,  Apr 15, 2008  8:25 AM ET by Lehman Brothers

Lehman Brothers rated Overweight Hologic, Inc. (NASDAQ: HOLX) on 04/15/2008. Previously Lehman Brothers rated Buy Hologic, Inc. (NASDAQ: HOLX) on 10/17/2007.,
when the stock price was $17.22. Since then, Hologic, Inc. has gained 128.35% as of 01/28/2016's recent price of $39.31.
If you would have followed the previous Lehman Brothers's recommendation on HOLX, you would have gained 128.34% of your investment in 3025 days.

Hologic Inc. is a leading supplier of high quality, innovative and clinically valuable diagnostic systems and tests. The company develops, manufactures and markets X-ray bone densitometers and ultrasound bone analyzers that address a growing market for osteoporosis prevention and treatment -- a key element of women's health care. The systems are used by more leading medical schools, universities and osteoporosis opinion leaders than any other bone densitometer.

Lehman Brothers Holdings Inc. has filed for bankruptcy protection in the U.S.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/15/2008 8:25 AM Buy
27.02 37.50
as of 12/24/2008
1 Week down  -4.09 %
1 Month up  10.33 %
3 Months up  25.32 %
1 YTD up  9.41 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/17/2007 9:25 AM Buy
17.22 18.75

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy